Celldex Therapeutics (CLDX) Posts Q3 Loss of 25c/Share

November 1, 2012 8:07 AM

Celldex Therapeutics (NASDAQ: CLDX) reported Q3 EPS of ($0.25), $0.01 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found